{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1383670320160603268.json","@type":"Researcher","foaf:Person":[{"foaf:name":[{"@value":"Gary Berman"}],"foaf:familyName":[{"@value":"Berman"}],"foaf:givenName":[{"@value":"Gary"}]}],"career":[{"institution":{"notation":[{"@value":"From Kool Kids Pediatrics, DM Clinical Research, Houston (K.A.); the Clinical Research Institute, Minneapolis (G.B.); and Moderna, Cambridge, MA (H.Z., W.D., V.F., M.C.-V., B.D., J.D., B.G., W.H., R.P., J.M.M., B.L., R.M.)."}]}}],"product":[{"@id":"https://cir.nii.ac.jp/crid/1363670320160603264","@type":"Article","productIdentifier":[{"@type":"DOI","@value":"10.1056/nejmoa2109522"},{"@type":"URI","@value":"http://www.nejm.org/doi/pdf/10.1056/NEJMoa2109522"}],"notation":[{"@value":"Evaluation of mRNA-1273 SARS-CoV-2 Vaccine in Adolescents"}],"relation":[{"type":"creator"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1056/nejmoa2109522_YjU0X3Z9BiPJFFGVUsOn5A5eG7l"}]}